Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Nalu Neurostimulation SCS system

K-Number: K201618 · 2020-07-15

Decision Date2020-07-15
Product CodeGZB
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

Nalu Neurostimulation SCS system is a medical device manufactured by Boston Scientific Neuromodulation. It received FDA 510(k) clearance on 2020-07-15 under approval number K201618. The device is classified under product code GZB. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Nalu Neurostimulation SCS system?

Nalu Neurostimulation SCS system is a medical device that received FDA 510(k) clearance on 2020-07-15. It is manufactured by Boston Scientific Neuromodulation. The 510(k) number is K201618.

When was Nalu Neurostimulation SCS system approved by the FDA?

Nalu Neurostimulation SCS system received FDA 510(k) clearance on 2020-07-15, under approval number K201618.

What company makes Nalu Neurostimulation SCS system?

Nalu Neurostimulation SCS system is manufactured by Boston Scientific Neuromodulation.

What is the FDA product code for Nalu Neurostimulation SCS system?

The FDA product code for Nalu Neurostimulation SCS system is GZB.

Related Clinical Trials

Other Devices by Boston Scientific Neuromodulation

View all 10 devices →

Related Devices (Code: GZB)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.